MIMs Growing Business Segments

1
(No Transcript)
2
MIMs Growing Business Segments
3
2003 Results

• 589 million Revenues
• 9 million Net Profit
• 0.41 EPS

4
Segment Revenue
1Q 2004 vs. 2003
PBM/Mail
Specialty
2004
2003
5
Segment Contribution to Profitability
1Q 2004 vs. 2003
PBM/Mail
Specialty
2004
2003
6
MIM PBM Services

• 200 payor clients
• Approximately 7 million lives under management
• Processed or delivered 12 million prescriptions

7
MIM BioScrip Competitive Value

• Payor-centric model
• Over 350 payor contracts with access to over 20
  million lives
• Clinical approach combined with education
• Center of excellence in specific disease state
  management
• Superior Reporting Capabilities

8
MIM BioScrip Competitive Value (Continued)

• National and local presence
• Regional physician sales force targeting
  specialists
• Specialized mixing fulfillment facilities
• Dominant player in NY metropolitan area
• Recently completed specialty acquisition

9
Disease States Driving Growth

• Crohns Disease Gauchers Disease
• Growth Hormone Deficiency HIV/AIDS
• Hemophilia Hepatitis C
• Immune Deficiency Infertility
• MS Oncology
• Psoriasis Renal Care
• Organ Transplant Rheumatoid Arthritis
• Provide all drugs across all therapeutic
  categories

10
Revenue Mix Among Disease States
11
MIM BioScrip PhilosophyPersonalized medicine
Payor-centric approachLocal relationships
12
(No Transcript)